Goldman Sachs Downgrades Aetna (AET) to Sell
More News related to AET
- Aetna and Pfizer Present ''State of Motion'' Health Fair in Hartford to Encourage Families to Adopt Healthy Lifestyles
- Enjoy 'Wellness on Us,' Aetna Tells Small Pa. Employers
- Congress, Stakeholders Make History Achieving Mental Health Parity
- Dental Care Can Reduce Risk of Preterm Birth by Nearly 50 Percent
- ActiveHealth Management Selects QualityMetric to Measure Health Status
More News related to Downgrades
- State Seeks Voter Fraud Probe In Lake County
- Local Voter Fraud Claims Rise
- Republican National Committee to Hold Conference Call Regarding Vote Fraud in Pennsylvania
- Radio Address by President Bush to the Nation
- MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
Goldman Sachs downgrades Aetna Inc. (NYSE: AET) from Neutral to Sell.
Aetna, Inc. operates as a diversified health care benefits company primarily in the United States and Canada.
Related Categories
DowngradesStocks Mentioned
+0.77Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
